drugset / Trial / NCT03632525

Intravenous Iron in Adults With Cystic Fibrosis

NCT03632525

Phase 4 Completed 20 enrolled University of Oxford
NaSingle-groupOpen-labelTreatment

Summary

This pilot interventional cohort study will examine the effects of intravenous iron in adults with cystic fibrosis and iron deficiency.

Timeline

Start
2019-02-22
Primary completion
2020-03-27
Completion
2021-10-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferric carboxymaltose Other / unclassified 20 mg/kg Intravenous